CL - Colgate-Palmolive Company
| Previous Close | 67.82 |
| Open | 67.88 |
| Bid | 68.24 x 800 |
| Ask | 68.25 x 1000 |
| Day's Range | 67.39 - 68.32 |
| 52 Week Range | 57.51 - 76.41 |
| Volume | 3022140 |
| Avg. Volume | 3,583,473 |
| Market Cap | 58B |
| Beta (3Y Monthly) | 0.70 |
| PE Ratio (TTM) | 25.27 |
| EPS (TTM) | 2.70 |
| Earnings Date | Jan 23, 2020 - Jan 27, 2020 |
| Forward Dividend & Yield | 1.72 (2.54%) |
| Ex-Dividend Date | 2019-10-22 |
| 1y Target Est | 71.47 |
- Zacks
The Zacks Analyst Blog Highlights: ExxonMobil, Starbucks, Diageo, Fidelity National Information Services and Colgate-Palmolive
The Zacks Analyst Blog Highlights: ExxonMobil, Starbucks, Diageo, Fidelity National Information Services and Colgate-Palmolive
- Zacks
Top Stock Reports for ExxonMobil, Starbucks & Diageo
Top Stock Reports for ExxonMobil, Starbucks & Diageo
- Simply Wall St.
Can You Imagine How Cresco Labs's (CNSX:CL) Shareholders Feel About The 23% Share Price Increase?
Some Cresco Labs Inc. (CNSX:CL) shareholders are probably rather concerned to see the share price fall 40% over the...
- Zacks
Stocks & ETFs to Profit From Cyber Monday Deals
While investing in any of the retail stocks could reward investors throughout Cyber Week, a diverse approach in a basket form can also be a great choice.
- Zacks
Colgate-Palmolive (CL) Down 1.1% Since Last Earnings Report: Can It Rebound?
Colgate-Palmolive (CL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Insider Monkey
Colgate-Palmolive Company (CL): Hedge Funds In Wait-and-See Mode
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset management firms do not gamble the hard-earned money of the people who are on the edge of poverty. Truth […]
- MarketWatch
Cannabis producer Cresco Labs reports revenue miss
Cresco Labs Inc. reported revenue Tuesday that missed Wall Street expectations. The weed producer reported a third-quarter net loss of $8.6 million, versus net income of $1.2 million in the year-ago quarter. Cresco did not report a per-share earnings figure. Revenue rose to $36.2 million from $12.7 million a year ago. Analysts polled by FactSet expected sales of $37.9 million. U.S. traded shares of Cresco Labs have dropped 14% this year, as the S&P 500 index has gained 25%. The ETFMG Alternative Harvest ETF has fallen 32% this year. Cresco shares closed up 0.7% in regular trading Tuesday.
- MarketWatch
Cresco Labs drops acquisition of VidaCann, raises $38 million in sale-and-leaseback deal
Cresco Labs said Tuesday it has terminated the acquisition of VidaCann Ltd. announced in March in a deal that would have cost it $120 million. Chicago-based Cresco Labs said the decision was made to conserve cash as it works to accelerate top and bottom-line growth. The company has also signed an agreement for a sale-and-leaseback of two properties in Ohio and Michigan that will allow it to raise $38 million in non-dilutive financing. "The team and operations at VidaCann are phenomenal, but with a focus on managing our cost of capital, and insuring the most efficient and highest return on invested capital, the ability to deploy resources to other, existing, Cresco markets that are widely considered some of the top markets in the US, like Illinois, Pennsylvania, California and Nevada, has to take priority," Chief Executive and co-Founder Charlie Bachtell said in a statement. The company is the latest to drop a planned acquisition as the cannabis sector has been hurt by the slower-than-expected development of the legal market in Canada and the U.S. U.S.-listed shares were not active premarket, but have fallen 15% in 2019, while the ETFMG Alternative Harvest ETF has fallen 31% and the S&P 500 has gained 25%.
- Thomson Reuters StreetEvents
Edited Transcript of CL earnings conference call or presentation 1-Nov-19 3:00pm GMT
Q3 2019 Colgate-Palmolive Co Earnings Call
- MarketWatch
Colgate reveals to competitors how it makes completely recyclable toothpaste tube
Colgate-Palmolive Co. will share the intellectual property of its new fully-recyclable toothpaste tube with competitors, a move that comes as the home-goods industry faces mounting pressure from eco-conscious shoppers.
- Business Wire
Colgate-Palmolive Receives 2019 Leadership Award from U.S. Green Building Council
Colgate-Palmolive Company received a U.S. Green Building Council (USGBC) 2019 Leadership Award in recognition of exemplary work and leadership in the green building industry. Colgate was honored for this achievement at the USGBC’s Greenbuild International Conference and Expo on November 20, marking a significant milestone in Colgate’s ongoing commitment to sustainable business practices.
- Business Wire
Colgate-Palmolive Ships World’s First Tube Recognized as Recyclable and Freely Shares its Breakthrough Technology
Colgate-Palmolive has begun the switch to a first-of-its-kind recyclable toothpaste tube and now wants to enlist other companies to follow its lead. Last week, Colgate delivered to retailers the first tube recognized by the Association of Plastic Recyclers (APR) -- Antiplaque & Whitening toothpaste under the Company’s Tom’s of Maine brand. Tom’s will complete the switch in 2020, when the Colgate brand will start the transition in Europe and North America.
- Business Wire
Colgate-Palmolive Webcasts Fireside Chat at the Morgan Stanley Global Consumer & Retail Conference
Colgate-Palmolive Group President, Latin America & Asia Pacific, Panagiotis Tsourapas, will participate in a fireside chat at the Morgan Stanley Global Consumer & Retail Conference on Wednesday, December 4, 2019 at 1:00 p.m.
- Zacks
Soap & Cleaning Materials Stock Outlook Buoyant on Innovation
Soap & Cleaning Materials Stock Outlook Buoyant on Innovation
- Simply Wall St.
Do You Like Colgate-Palmolive Company (NYSE:CL) At This P/E Ratio?
The goal of this article is to teach you how to use price to earnings ratios (P/E ratios). We'll show how you can use...
- InvestorPlace
8 Dividend Aristocrat Stocks to Buy Now
Even though the U.S.-China trade war is seemingly easing, it could flare back up again at any time. As a result, many investors are still looking for defensive stocks to buy now. Of course, in the most extreme example, you can elect to go all into cash. However, history has proven that to be the worst thing to do. Instead, this is a good time to consider dividend aristocrats.First, market uncertainty incentivizes stable dividend stocks to buy now. How so? Passive-income generating companies typically perform better than high-flying growth names during bearish phases. For one thing, investors can still collect their payouts even if their portfolio isn't doing too well. Moreover, organizations that have a history of consistent payouts tend to be levered toward secular or otherwise steady industries.And there's no better paragon of stability than dividend aristocrats. For those who are unfamiliar with the term, dividend aristocrats have three main requirements: they must be equities traded in the S&P 500, have 25 years-plus of dividend increases and meet size/liquidity benchmarks.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 7 Large-Cap Stocks to Give a Wide Berth However, a word of caution. Just because you put dividend aristocrats in your list of stocks to buy now doesn't guarantee a smooth ride. If the markets turn volatile, you can expect virtually all names to incur red ink.But the major selling point is magnitude. With dividend aristocrats, you're limiting your potential losses due to the robustness of the target company. Better yet, the volatility provides a rare discount for these stalwarts of industry.So with that in mind, here are eight stocks to buy now with a long track record of payouts: Stocks to Buy: McDonald's (MCD)Source: Shutterstock Dividend Yield: 2.6%I'm going to start my list of stocks to buy now with a name I was wrong about: McDonald's (NYSE:MCD). One of the reasons why I didn't like MCD stock was that the Golden Arches apparently wasn't winning over millennials. But recently, I started eating out at McDonald's, and I discovered that the real fundamentals don't match the "paper" data.For instance, the McDonald's app is incredibly convenient. You order what you want on your phone and go up to the counter or the drive-thru. Very quickly, their employees deliver your selected items. And let's talk about the drive-thru: it's lightning-quick, even with rows of waiting cars. That's a major plus for MCD stock.Finally, McDonald's is a proud member of the dividend aristocrats. It has increased its payout consistently over a 43-year period. If a downturn were to impact the markets, MCD stock is a name you'll want to own. Colgate-Palmolive (CL)Source: Shutterstock Dividend Yield: 2.6%When you're on the hunt for stable stocks to buy now, you don't want to get too cute. Instead, you'll want to go with a proven name like Colgate-Palmolive (NYSE:CL). The investment thesis for CL stock is straightforward and simple. Even in times of recession, people still need to brush their teeth. Thus, I expect a steady revenue stream no matter what happens in the coming months and years. * 7 Large-Cap Stocks to Give a Wide Berth I believe CL stock will give you excellent protection over the coming months. Keep in mind that Colgate-Palmolive has increased their dividends for 55 years. That's an impressive feat, even compared to other dividend aristocrats. Further, it's a status that management won't give up without a fight. Cardinal Health (CAH)Source: Shutterstock Dividend Yield: 3.6%In recent years, the healthcare sector has suffered a black eye from a public relations standpoint. Thus, it's no surprise that many companies in this segment have faltered. However, I'd consider putting Cardinal Health (NYSE:CAH) on your list of stocks to buy now. Unlike other players in this broad category, CAH stock is strongly levered to secular demand.In other words, Cardinal Health has a wide range of professional medical products. They run the gamut from anesthesia-related equipment to laboratory products down to something as mundane as gloves. While medical technology is always improving, some things will always remain the same. For these everyday concerns in the medical field, Cardinal Health has folks covered. Ultimately, that's a great catalyst for CAH stock.Another factor is that the company very much belongs on the list of dividend aristocrats. While the exact number of dividend increases causes some disagreement, CAH is included in the Proshares S&P 500 Dividend Aristocrats ETF (BATS:NOBL). And whatever the case, it has reliably raised dividends for at least the last 14 years. Aflac (AFL)Source: Shutterstock Dividend Yield: 2%Simply put, Aflac (NYSE:AFL) is a great company with an incredibly relevant service. As you no doubt have learned through their quirky commercials, Aflac specializes in supplemental insurance. Essentially, their range of products protect you financially from incidents that "regular" insurance doesn't cover or cover adequately. Plus, their solutions represent an incremental cost for much peace of mind, bolstering the case for AFL stock.And while most millennials probably think they're invincible, many will encounter situations that give them a reality check. Additionally, they may hear horror stories about how coverage gaps financially ruined one of their peers. Whatever the case, Aflac, and by logical deduction, AFL stock, has opportunities to rise through word of mouth. * 7 Large-Cap Stocks to Give a Wide Berth Finally, Aflac is one of the most stable stocks to buy now among dividend aristocrats. Kimberly-Clark (KMB)Source: Shutterstock Dividend Yield: 3.1%I don't always prepare for recessions. But when I do, I take a long look at Kimberly-Clark (NYSE:KMB). If you're concerned about a prolonged downturn in the U.S. or global economy, you'll also want to consider KMB stock. As with Colgate-Palmolive, the bullish argument here is very simple: even in recessions, people need to use the bathroom.And without getting graphic, people also need to take care of themselves after a lengthy session with the porcelain throne. Kimberly-Clark offers some of the best products for this endeavor, and I speak from personal experience. Moreover, the company has other family-care products. If you think about it, KMB stock is truly a cradle-to-grave investment.Kimberly-Clark has traded among dividend aristocrats for 46 years. That makes its shares one of the stocks to buy now in my book. Chevron (CVX)Source: Shutterstock Dividend Yield: 3.9%With the U.S. and China trading barbs and sanctions, it's no surprise that oil companies like Chevron (NYSE:CVX) fell. On surface level, CVX stock currently faces two major headwinds. First, global volatility means lower demand overall for energy. Second, the push for clean and renewable energies makes CVX stock appear antiquated, and perhaps soon approaching irrelevancy.Admittedly, the first point is going to be a major distraction for Chevron. However, even in the middle of a recession, people still require transportation. Thus, I don't see demand falling completely off the cliff. On the second point, I believe green energy is more a gimmick than a practical reality. Our infrastructure is simply not ready to accommodate innovations like electric vehicles on a mass scale. * 7 Large-Cap Stocks to Give a Wide Berth Granted, CVX stock is a risky play among this list of stocks to buy now. That said, the trade war dynamic should drive shares to an attractive discount. At that point, I think Chevron becomes a bargain because the world still needs fossil-fuel-based energy. AT&T (T)Source: Shutterstock Dividend Yield: 5.2%With AT&T (NYSE:T), we're really getting into the riskier side of the dividend stocks to buy now. I say this for a couple of reasons. One, with a yield of 5.2%, sustainability becomes a concern. Second, and a perfect segue, the dividend payout ratio for T stock is on-paper astronomical. Therefore, many bears anticipate that AT&T will lose its status as one of the key dividend aristocrats.However, it's important to point out that telecoms usually have extremely large depreciation and amortization costs. That artificially depresses earnings, which makes the high payout ratio somewhat deceptive. Still, I concede the point that T stock is saddled with an unprecedented debt level. Its big-moat, slow-growth narrative is distracting, especially when we may be headed toward a recession.That said, this criticism focuses on the headline print. In reality, AT&T is one of very few companies that have the resources and know-how to roll out the 5G network. And because we're in a tech cold war with international adversaries, I see the government supporting T stock big time. 3M (MMM)Source: Shutterstock Dividend Yield: 3.4%Last on my list of stocks to buy now is applied-sciences firm 3M (NYSE:MMM). After providing largely steady gains over the last several decades, MMM stock is in trouble. Hitting a peak around February of 2018, shares have formed an ugly bearish trend channel. Efforts to time the bottom have badly bruised speculators.Surely, I'm not alone when I say that I dislike the phrase "this time, it's different." It's almost bad karma to use those words when discussing an investment thesis. However, I genuinely believe that with MMM stock, this is a valid descriptor.One of the toughest challenges for MMM stock is that the underlying company didn't have a relevant product. That calculus has changed with their latest "Flex & Seal Shipping Roll." Essentially, this is a customizable shipping package that doesn't require tape or other cumbersome equipment.Looking at the video demonstration of Flex & Seal, I think it's a game-changer for retail. By logical deduction, then, it's a game-changer for MMM stock.As of this writing, Josh Enomoto is long T stock. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Large-Cap Stocks to Give a Wide Berth * 7 Potential New Stocks That Should Not Go Public * 5 Chinese Stocks to Buy Surging Higher The post 8 Dividend Aristocrat Stocks to Buy Now appeared first on InvestorPlace.
- Investopedia
Procter & Gamble Retests Highs After Solid Earnings
Procter & Gamble shares moved higher after the company reported stronger-than-expected earnings, but traders will be keeping an eye on these levels.
- Market Realist
Charlotte’s Web: Top Four Things to Know about the Stock
Last month, Charlotte's Web announced that it would partner with Nielsen to guide US retail companies on the growth of the CBD (cannabidiol) space.
- MarketWatch
Coca-Cola, Nestlé and Pepsi top this list of plastic violators, and there’s been a solar breakthrough from Sweden
Evidence of the increasing effects of climate change is building, as are the investing opportunities and changes in consumer habits linked to environmental concerns and resource use. Here are select dispatches about the companies responding to customer demands and climate risk, the ESG investors and their advisers, and the policy-makers, enterprising individuals and scientists preparing for tomorrow. BreakFreeFromPlastic, a three-year-old organization of some 1,800 members working to tackle plastic pollution has called in the volunteers that tally top plastic polluters by brand, and the amount of refuse clogging the world’s waterways remains alarming.
- GuruFocus.com
Ratio Analysis: The Acid-Test Ratio
A stricter version of the current ratio, for those who need to know which short-term assets are available to meet current liabilities Continue reading...
- MarketWatch
S&P500 and Nasdaq hit new records after October jobs numbers beat expectations
Stocks rallied Friday, with the benchmark S&P 500 and Nasdaq Composite indexes notching new closing records, after the Labor Department estimated the U.S. economy added 128,000 new jobs in October and upwardly revised its estimate of job growth in September and August.
- MarketWatch
Cannabis stocks fall as Curaleaf becomes latest company to scale back a big acquisition
Cannabis stocks were mostly lower Thursday, led by Curaleaf Holdings, after the company became the latest to scale back a previously announced acquisition in the wake of a massive re-rating of the sector in the past few months.
- MarketWatch
Facebook and Alphabet stocks in trouble over antitrust fears, warns Goldman
Earnings continue to take center stage on Friday, ably supported by the twists and turns of the U.S.-China trade war.
- Barrons.com
Colgate Stock Dips Amid Concerns Over Margins
Shares of Colgate-Palmolive were lower midday Friday as at least one analyst expressed disappointment about margin performance in the company’s third-quarter earnings.
- Market Realist
Why Colgate-Palmolive’s Q3 Earnings Failed to Impress
Colgate-Palmolive released its third-quarter earnings results today. The company's performance was mixed, irking investors.
